近日，南瑞生醫(yī)療科技有限公司眼科器械及生物材料研發(fā)產(chǎn)業(yè)基地正式落戶梅溪湖二期,。

Nanruisheng Medical Technology Co. Ltd. will open its ophthalmic device and biomaterial R&D industrial base in Meixi Lake Phase II in Changsha.

該研發(fā)產(chǎn)業(yè)基地擬投資20億元，占地面積超2萬平方米,，主要生產(chǎn)和研發(fā)眼科器械原材料,、眼科高值耗材、視力保健等專業(yè)眼科產(chǎn)品,。

Spanning over 20,000 square meters, this 2-billion-yuan R&D facility will primarily produce and develop raw materials for ophthalmic devices, high-value ophthalmic consumables, vision care products, and other specialized ophthalmic products.

未來,，瑞生醫(yī)療有望能把自主研發(fā)的眼科產(chǎn)品，帶到國際市場上亮相,。

The center looks to bring its eye care products to customers across the globe.